Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
592 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02459964 | Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain | completed | Phase 4 | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 16, 2021 | clinicaltrials |
| NCT00847912 | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial(VAKCCT) | completed | Phase 4 | 954 | VA Office of Research and DevelopmentFED | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01789281 | Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. | completed | Phase 4 | 34 | Novartis PharmaceuticalsINDUSTRY | 9 | Jun 11, 2021 | clinicaltrials |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer(REAL) | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT00414765 | Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma | completed | Phase 4 | 26 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 8, 2021 | clinicaltrials |
| NCT00622505 | Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants(Z-MARK) | completed | Phase 4 | 121 | Novartis PharmaceuticalsINDUSTRY | 1 | May 26, 2021 | clinicaltrials |
| NCT01131325 | Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148) | terminated | Phase 4 | 3 | Novartis PharmaceuticalsINDUSTRY | 1 | May 20, 2021 | clinicaltrials |
| NCT03469310 | Minimizing Narcotic Analgesics After Endocrine Surgery | completed | Phase 4 | 126 | Minerva A Romero ArenasOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT02796755 | Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation | completed | Phase 4 | 30 | Emory UniversityOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT01968798 | ASPREE Cancer Endpoints Study(ACES) | unknown | Phase 4 | 14,500 | Hennepin Healthcare Research InstituteOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03630198 | Pain Outcomes Following Intralesional Corticosteroid Injections | completed | Phase 4 | 31 | Vanderbilt University Medical CenterOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT03038152 | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03723447 | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)(TINGLE) | completed | Phase 4 | 102 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT01683188 | HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma(PROCLIVITY01) | terminated | Phase 4 | 53 | Clinigen, Inc.INDUSTRY | 1 | Feb 1, 2021 | clinicaltrials |
| NCT00381095 | A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer(COPE) | terminated | Phase 4 | 152 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 19 | Jan 20, 2021 | clinicaltrials |
| NCT02052557 | The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery | completed | Phase 4 | 51 | Des Moines UniversityOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT01739764 | An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol | completed | Phase 4 | 215 | Hoffmann-La RocheINDUSTRY | 25 | Jan 7, 2021 | clinicaltrials |
| NCT01101750 | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? | completed | Phase 4 | 25 | Medstar Health Research InstituteOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT00304291 | A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) | completed | Phase 4 | 5 | State University of New York at BuffaloOTHER | 1 | Dec 28, 2020 | clinicaltrials |
| NCT01264965 | Non-cancer Pain and Cognitive Impairment: A Disabling Relationship | terminated | Phase 4 | 25 | University of ChicagoOTHER | 1 | Dec 11, 2020 | clinicaltrials |
| NCT02946918 | Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy | terminated | Phase 4 | 14 | University of Texas Southwestern Medical CenterOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT01548768 | RHYTHM (Formerly Escape II Myocardium)(RHYTHM) | completed | Phase 4 | 149 | Columbia UniversityOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03210376 | Neuromuscular Blockade on Shoulder Pain of Elderly | completed | Phase 4 | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03176849 | A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT | completed | Phase 4 | 49 | Phoenix Children's HospitalOTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT00395863 | Multihance at 3 Tesla (3T) in Brain Tumors | completed | Phase 4 | 46 | Bracco Diagnostics, IncINDUSTRY | 1 | Nov 5, 2020 | clinicaltrials |
| NCT03423082 | Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. | terminated | Phase 4 | 1 | Nghi NguyenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT03107325 | Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging | withdrawn | Phase 4 | 0 | Boston Children's HospitalOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT03642457 | Efficacy Between Serratus Plane Block And Local Infiltration In Vats | terminated | Phase 4 | 65 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Sep 30, 2020 | clinicaltrials |
| NCT01199198 | Tolvaptan in Hyponatremic Cancer Patients | completed | Phase 4 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT03138967 | Investigation of Sugammadex in Outpatient Urological Procedures | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT02822196 | Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies | withdrawn | Phase 4 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | completed | Phase 4 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT03959852 | Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain | terminated | Phase 4 | 6 | Mercy Health OhioOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT03006562 | PREvention of VENous ThromboEmbolism Following Radical Prostatectomy(PREVENTER) | terminated | Phase 4 | 501 | Johns Hopkins UniversityOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT02287675 | Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer(Lymphoseek) | completed | Phase 4 | 40 | Kettering Health NetworkOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT03199911 | Topical Antibiotic Prophylaxis for Eyelids | completed | Phase 4 | 401 | University of California, San FranciscoOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT02032784 | Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding | terminated | Phase 4 | 33 | AdventHealthOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT03714867 | Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery | withdrawn | Phase 4 | 0 | Augusta UniversityOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT03891979 | Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma | withdrawn | Phase 4 | 0 | NYU Langone HealthOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT03482583 | Tobacco Use Treatment in Cancer Patients | completed | Phase 4 | 90 | University of FloridaOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT02122380 | The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome | completed | Phase 4 | 23 | Vanderbilt UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT01982539 | Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute | completed | Phase 4 | 25 | DepomedINDUSTRY | 1 | May 7, 2020 | clinicaltrials |
| NCT01344356 | Stereotactic Body Radiotherapy for Head and Neck Tumors | completed | Phase 4 | 19 | Mercy ResearchOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT02812186 | Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery | completed | Phase 4 | 79 | Stony Brook UniversityOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02514174 | Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older | completed | Phase 4 | 25 | Boehringer IngelheimINDUSTRY | 1 | Mar 30, 2020 | clinicaltrials |
| NCT03823950 | Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients | unknown | Phase 4 | 150 | University of Mississippi Medical CenterOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT03349463 | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | unknown | Phase 4 | 30 | Bital Savir-BaruchOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT03513757 | Dexmedetomidine and Propofol for Pediatric MRI Sedation | completed | Phase 4 | 40 | Medical College of WisconsinOTHER | 1 | Feb 21, 2020 | clinicaltrials |
| NCT02451488 | Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma | completed | Phase 4 | 8 | Mayo ClinicOTHER | 1 | Feb 10, 2020 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials